Cliff Asness's RNA Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 14,149 shares of Avidity Biosciences, Inc. (RNA) worth $1.02 M, representing 0.00% of the portfolio. First purchased in 2024-Q2, this short-term holding has been held for 6 quarters.
Based on 13F filings, Cliff Asness has maintained this position in RNA for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 14,149 shares. Largest reduction occurred in Q4 2024, reducing 11,892 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Avidity Biosciences (RNA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Avidity Biosciences (RNA) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +14,149 | New Buy | 14,149 | $72.13 |
| Q2 2025 | -10,785 | Sold Out | 0 | $0.00 |
| Q1 2025 | -2,276 | Reduce 17.43% | 10,785 | $29.52 |
| Q4 2024 | -11,892 | Reduce 47.66% | 13,061 | $29.08 |
| Q3 2024 | +12,911 | Add 107.22% | 24,953 | $45.93 |
| Q2 2024 | +12,042 | New Buy | 12,042 | $40.85 |
Cliff Asness's Avidity Biosciences Investment FAQs
Cliff Asness first purchased Avidity Biosciences, Inc. (RNA) in Q2 2024, acquiring 12,042 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Avidity Biosciences, Inc. (RNA) for 6 quarters since Q2 2024.
Cliff Asness's largest addition to Avidity Biosciences, Inc. (RNA) was in Q4 2025, adding 14,149 shares worth $1.02 M.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 14,149 shares of Avidity Biosciences, Inc. (RNA), valued at approximately $1.02 M.
As of the Q4 2025 filing, Avidity Biosciences, Inc. (RNA) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Avidity Biosciences, Inc. (RNA) was 24,953 shares, as reported at the end of Q3 2024.